Dozens of explosions were reported in Ukraine and near Russian-occupied Crimea early Wednesday, as both sides stepped up air attacks… Read More »Russia and Ukraine step up airstrikes ahead of expected counteroffensive
Good morning. This article is an on-site version of our First FT newsletter. Subscribe to our Asia, Europe/Africa Or Americas… Read More »FirstFT: Russian spy ring smuggles sensitive EU tech despite sanctions
Almost a third of over-65s in Britain are ‘uncomfortable’ with online banking, putting them at risk of financial exclusion as… Read More »A third of UK over-65s ‘uncomfortable’ with online banking
First Republic’s bailout this week failed to halt a selloff in regional bank stocks, which plunged Tuesday morning as investors… Read More »First Republic bailout fails to halt fall in US regional bank stocks
This article is an on-site version of our Energy Source newsletter. register here to receive the newsletter directly in your… Read More »America’s chief cleantech lender has a ‘ridiculously good rate of return’
Daniel Davies is Managing Director at Frontline Analysts, the author of lie for moneyand co-author of The Brompton. If you… Read More »Read the “Assessment of the European Central Bank’s Prudential Review and Evaluation Process” so you don’t have to
What to watch in Asia today FT journalists Singapore-based DBS Group releases first-quarter performance data in one of several earnings… Read More »Live news: EY’s global CEO says planned split ‘is on hiatus for a while’
Recep Tayyip Erdoğan has claimed Turkish forces killed the leader of the Islamist militant group Isis during an operation in… Read More »Erdoğan claims ISIS leader was killed in operation by Turkish forces
Good morning. This article is an on-site version of our First FT newsletter. Subscribe to our Asia, Europe/Africa Or Americas… Read More »FirstFT: The second largest bank failure in US history
Astellas Pharma has agreed to buy U.S. biotech group Iveric Bio for approximately $5.9 billion, marking the Japanese drugmaker’s largest-ever… Read More »Japan’s Astellas to buy Iveric Bio for $5.9 billion in US biotech deal